We are maintaining our Neutral recommendation on Theravance ( THRX ) with a target price of $28.00. The stock carries a Zacks #3 Rank (Hold rating) in the short run.
We are reiterating our Neutral recommendation on the shares of Reinsurance Group of America ( RGA ) prior to its third quarter earnings release, scheduled on October 22, 2012.
We recently maintained a Neutral recommendation on Embraer S.A. ( ERJ ), a Brazilian aircraft and aviation-related structural parts manufacturer. Apparently, things are not going